Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2026-06-14 @ 7:46 PM
Study NCT ID:
NCT01652703
Status:
COMPLETED
Last Update Posted:
2018-11-28
First Post:
2012-07-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2013-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2012-07-26
First Submit QC Date:
None
Study First Post Date:
2012-07-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-03
Results First Submit QC Date:
None
Results First Post Date:
2015-10-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-05-26
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-11-01
Last Update Post Date:
2018-11-28
Last Update Post Date Type:
ACTUAL